Page 73 - THE EVOLUTION OF EARLY ARTHRITIS AND CARDIOVASCULAR RISK Samina A. Turk
P. 73
HOW DOES ESTABLISHED RHEUMATOID ARTHRITIS DEVELOP
94. Emery P, Durez P, Dougados M, Legerton CW, Becker JC, Vratsanos G, et al. Impact of
T-cell costimulation modulation in patients with undifferentiated inflammatory arthritis
or very early rheumatoid arthritis: a clinical and imaging study of abatacept (the ADJUST
trial). Annals of the rheumatic diseases 2010;69(3):510-516. 3
95. vanEijkIC,NielenMM,vanderHorst-BruinsmaI,TijhuisGJ,BoersM,DijkmansBA,etal. Aggressive therapy in patients with early arthritis results in similar outcome compared with conventional care: the STREAM randomized trial. Rheumatology 2012;51(4):686- 694.
96. *HeimansL,Wevers-deBoerKV,VisserK,GoekoopRJ,vanOosterhoutM,HarbersJB,et al. A two-step treatment strategy trial in patients with early arthritis aimed at achieving remission: the IMPROVED study. Annals of the rheumatic diseases 2014;73(7):1356- 1361.
97. Smolen JS, Landewe R, Breedveld FC, Buch M, Burmester G, Dougados M, et al. EULAR recommendations for the management of rheumatoid arthritis with synthetic and biological disease-modifying antirheumatic drugs: 2013 update. Annals of the rheumatic diseases 2014;73(3):492-509.
98. van Herwaarden N, den Broeder AA, Jacobs W, van der Maas A, Bijlsma JW, van Vollenhoven RF, et al. Down-titration and discontinuation strategies of tumor necrosis factor-blocking agents for rheumatoid arthritis in patients with low disease activity. The Cochrane database of systematic reviews. 2014;9:CD010455.
99. van Herwaarden N, van der Maas A, Minten MJ, van den Hoogen FH, Kievit W, van Vollenhoven RF, et al. Disease activity guided dose reduction and withdrawal of adalimumab or etanercept compared with usual care in rheumatoid arthritis: open label, randomised controlled, non-inferiority trial. British medical journal 2015;350:h1389.
100.Fautrel B, Pham T, Alfaiate T, Gandjbakhch F, Foltz V, Morel J, et al. Step-down strategy of spacing TNF-blocker injections for established rheumatoid arthritis in remission: results of the multicentre non-inferiority randomised open-label controlled trial (STRASS: Spacing of TNF-blocker injections in Rheumatoid ArthritiS Study). Annals of the rheumatic diseases 2015 [Epub 2015 Jun 23].
71
